fra project

8/10/2019 FRA Project

1/30

(Rs in Crs)

Year Dec 13 Dec-12 Dec-11 Dec-10 Dec-09

INCOME :

Sales Turnover 2619.37 2696.48 2429.58 2155.08 1912.77

Excise Duty 73.22 70.04 53.7 43.44 40.12

Net Sales 2546.15 2626.44 2375.88 2111.64 1872.65

Other Income 229.31 197.35 159.95 147.73 152.87

Stock Adjustments 50.75 -52.59 56.09 20.19 32.41

Total Income 2826.21 2771.2 2591.92 2279.56 2057.93

EXPENDITURE :Raw Materials 1208.57 1045.26 964.6 797.19 724.63

Power & Fuel Cost 23.85 22.5 26.7 26.75 24.66

Employee Cost 362.09 393.57 287.49 234.53 203.98

Other Manufacturing Expenses 90.91 64.57 74.5 64.69 59.67

Selling and Administration Expenses 321.06 286.05 269.01 246.75 219.69

Miscellaneous Expenses 70.51 94.84 349.82 50.63 35.3

Total Expenditure 2077 1906.79 1972.12 1420.54 1267.93

Operating Profit 749.2 864.4 619.8 859.02 790

Interest 0 0 0.33 0.62 0.37

Gross Profit 749.2 864.4 619.47 858.4 789.63

Depreciation(Current Year) 19.88 17.84 20.41 17.63 16.37 Profit Before Tax 729.32 846.56 599.06 840.77 773.26

Tax 233 294.38 180.68 288.78 274.22

Fringe Benefit tax 0 0 -7.15 0 1.85

Deferred Tax -5.57 -25.07 -5.07 -11.7 -15.1

Reported Net Profit 501.88 577.26 430.6 563.69 512.29

Extraordinary Items 18.98 -96.56 -160.67 -17.04 9.78

Adjusted Net Profit 482.9 673.82 591.27 580.73 502.51

P & L Balance brought forward 1142.95 1110.59 1164.53 1049.23 882.41

Appropriations 544.9 544.9 484.54 448.39 345.47

P & L Balance carried down 1099.93 1142.95 1110.59 1164.53 1049.23

Dividend 423.52 423.52 381.16 338.81 254.11

Equity Dividend % 500 500 450 400 300

Earnings Per Share-Unit Curr 50.85 60.63 43.72 60.27 55.74

Book Value-Unit Curr 238.15 237.3 226.67 227.96 207.69

Profit and L

Glaxosmithkline Pharma Ltd


2/30

http://www.capitaline.com/user/framepage.asp?id=1 19.05 PM, 10th August

http://www.indiainfoline.com/Markets/Company/Fundamentals/Profit-Loss/Sanofi-India-Ltd/50067

http://www.indiainfoline.com/Markets/Company/Fundamentals/Profit-Loss/Glaxosmithkline-Pharm
http://www.capitaline.com/user/framepage.asp?id=1%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2019.05%20PM,%2010th%20Augusthttp://www.capitaline.com/user/framepage.asp?id=1%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%20%2019.05%20PM,%2010th%20August


3/30

(Rs in Crs)

Year Dec 13 Dec-12 Dec-11 Dec-10 Dec-09

INCOME :

Sales Turnover 1,854.85 1,612.82 1,330.20 1,107.26 995.79

Excise Duty 45.99 39.78 28.86 22.31 21.38

Net Sales 1,808.86 1,573.04 1,301.34 1,084.95 974.41

Other Income 83.24 41.17 155.61 267.42 167.35

Stock Adjustments 9.47 8.93 10.12 12.03 23.46

Total Income 1,901.57 1,623.14 1,467.07 1,364.40 1,165.22

EXPENDITURE :Raw Materials 828.9 744.42 626.93 551.02 505.42

Power & Fuel Cost 41.83 34.15 27.08 21.08 19.5

Employee Cost 242.13 213.78 176.42 161.25 141.03

Other Manufacturing Expenses 51.26 49.43 45.81 46.9 39.71

Selling and Administration Expenses 306.76 280.89 235.2 214.16 180.61

Miscellaneous Expenses -50.45 -52.51 40.08 37.62 20.07

Total Expenditure 1,420.43 1,270.16 1,151.52 1,032.03 906.34

Operating Profit 481.14 352.98 315.55 332.37 258.88

Interest 0.42 1.4 0.42 2.89 0.07

Gross Profit 480.72 351.58 315.13 329.48 258.81

Depreciation(Current Year) 92.26 89.87 31.15 19.74 17.34 Profit Before Tax 388.46 261.71 283.98 309.74 241.47

Tax 107.87 72.23 74.32 74.27 81.24

Fringe Benefit tax 0 0 0 0 2.07

Deferred Tax 15.41 12.82 18.48 4.72 0.74

Reported Net Profit 265.18 176.66 191.18 230.75 157.42

Extraordinary Items 25.22 -0.05 -0.01 75.53 -0.16

Adjusted Net Profit 239.96 176.71 191.19 155.22 157.58

P & L Balance brought forward 913.32 842.65 758.45 698.34 610.55

Appropriations 148.28 105.99 106.98 170.64 69.63

P & L Balance carried down 1,030.22 913.32 842.65 758.45 698.34

Dividend 103.64 76 76 126.67 46.06

Equity Dividend % 450 330 330 550 200

Earnings Per Share-Unit Curr 107.28 71.36 77.86 91.12 64.95

Book Value-Unit Curr 580.3 518.02 479.67 434.81 398.68

ss Account Details

Sanofi India Ltd


4/30

4

a-Ltd/500660


5/30

(Rs in Crs)

Year Dec 13 Dec 12 Dec 11 Dec 10

SOURCES OF FUNDS :

Share Capital 84.7 84.7 84.7 84.7

Reserves Total 1,932.49 1,925.31 1,835.23 1,846.11

Total Shareholders Funds 2,017.19 2,010.01 1,919.93 1,930.81

Secured Loans 0 0 0 0

Unsecured Loans (Deferred Tax) 4.14 4.59 4.9 5.16

Total Debt 4.14 4.59 4.9 5.16

Other Liabilities 246.01 239.76 228.56 0

Total Liabilities 2,267.34 2,254.36 2,153.39 1,935.97

APPLICATION OF FUNDS :

Gross Block 299.08 272.04 271.66 318.4

Less : Accumulated Depreciation 199.01 182.63 172.53 209.47

Net Block 100.07 89.41 99.13 108.93

Capital Work in Progress 61.86 43.79 16.19 8.72

Investments 57.67 102.58 159.8 160.35

Current Assets, Loans & Advances

Inventories 342.4 282.04 330.14 281.54Sundry Debtors 96.39 115.9 85.31 47.02

Cash and Bank 2,027.14 2,038.78 1,984.09 1,948.08

Loans and Advances 125.8 130.77 112.73 171.69

Total Current Assets 2,591.73 2,567.49 2,512.27 2,448.33

Less : Current Liabilities and Provisions

Current Liabilities 363.7 323.09 266.4 346.22

Provisions 518.83 512.21 591.27 500.54

Total Current Liabilities 882.53 835.3 857.67 846.76

Net Current Assets 1,709.20 1,732.19 1,654.60 1,601.57

Deferred Tax Assets 96.9 89.75 67.43 65.14

Deferred Tax Liability 4.79 3.21 5.96 8.74

Net Deferred Tax 92.11 86.54 61.47 56.4

Other Assets 246.43 199.87 162.2 0

Total Assets 2,267.34 2,254.37 2,153.39 1,935.97

Contingent Liabilities 327.5 228.4 277.32 214.51

B



6/30

http://www.indiainfoline.com/Markets/Comp

any/Fundamentals/Balance-

Sheet/Glaxosmithkline-Pharma-Ltd/500660 10th August 2014, 20:41

http://www.indiainfoline.com/Markets/Comp

any/Fundamentals/Balance-Sheet/Sanofi-

India-Ltd/500674 10th August 2014, 20:43

Current Ratio = (Current Assets)/(Current

Liabilities) Glaxo Sanofi Industry

Dec 09 2.49 3.66 2.2

Dec 10 2.99 3.27 2.1

Dec 11 2.96 2.42 0.97

Dec 12 3.08 1.88 1.57

Dec 13 3.1 1.96 3.35


7/30

(Rs in Crs)

Dec 09 Year Dec 13 Dec 12 Dec 11 Dec 10

SOURCES OF FUNDS :

84.7 Share Capital 23.03 23.03 23.03 23.03

1,674.45 Reserves Total 1,323.67 1,181.09 1,093.59 991.12

1,759.15 Total Shareholders Funds 1,346.70 1,204.12 1,116.62 1,014.15

0 Secured Loans 0 0 0 0

5.42 Unsecured Loans 0 0 0 0

5.42 Total Debt 0 0 0 0

0 Other Liabilities 26.02 19.28 20.56 0

1,764.57 Total Liabilities 1,372.72 1,223.40 1,137.18 1,014.15

APPLICATION OF FUNDS :

289.18 Gross Block 1,102.18 1,014.38 967.92 375.5

196.37 Less : Accumulated Depreciation 403.63 315.02 230.95 204.45

92.81 Net Block 698.55 699.36 736.97 171.05

21.36 Capital Work in Progress 136.2 43.47 22.86 13.3

190.91 Investments 0.24 0.36 0.36 0.36

Current Assets, Loans & Advances

253.02 Inventories 340 272.45 254.27 238.4753.73 Sundry Debtors 118.31 98.9 104.09 60.44

1,672.60 Cash and Bank 264.4 430.2 234.23 655.35

135.07 Loans and Advances 224.43 27.1 74.15 259.59

2,114.42 Total Current Assets 947.14 828.65 666.74 1,213.85

Less : Current Liabilities and Provisions

316.66 Current Liabilities 277.03 238.16 218.54 173.7

382.96 Provisions 158.35 148.47 138.36 220.56

699.62 Total Current Liabilities 435.38 386.63 356.9 394.26

1,414.80 Net Current Assets 511.76 442.02 309.84 819.59

52.28 Deferred Tax Assets 28.47 26.19 22.81 25.32

7.59 Deferred Tax Liability 65.16 47.47 31.27 15.47

44.69 Net Deferred Tax -36.69 -21.28 -8.46 9.85

0 Other Assets 62.66 59.47 75.61 0

1,764.57 Total Assets 1,372.72 1,223.40 1,137.18 1,014.15

204.66 Contingent Liabilities 147.75 119.44 143.58 115.36

lance Sheet Details

Sanofi India Ltd


8/30


9/30

Dec 09

23.03

908.76

931.79

0

0

0

0

931.79

334.57

189.68

144.89

27.14

5.19

231.1452.73

585.95

143.72

1,013.54

158.17

115.37

273.54

740

29.8

15.23

14.57

0

931.79

140.51


10/30

Net Profit Margin

Operating Ratio

Divident Payout Ratio(Equity) Only 2

Liquidity Ratios

Current Ratio = (Current

Assets)/(Current Liabilities)Glaxo Sanofi Industry

Dec 09 2.49 3.66 2.2

Dec 10 2.99 3.27 2.1

Dec 11 2.96 2.42 0.97

Dec 12 3.08 1.88 1.57

Dec 13 1.96 3.35

Inventory T.O = (Cost ofGoods Sold-COGS)/Inventory

Glaxo Sanofi Industry

Dec 09 7.95 4.93 -

Dec 10 8.06 4.72 -

Dec 11 7.94 5.4 6.65

Dec 12 8.81 6.12 5.35

Dec 13 8.39 6.06 4.28

Receivables or Debtors

Turnover Glaxo Sanofi Industry

Dec 09 34.26 14 -Dec 10 42.78 19.57 -

Dec 11 36.72 16.17 11.69

Dec 12 26.8 15.89 9.9

Dec 13 24.68 17.08 8.02

EPS Glaxo Sanofi

2010 60.3 91.1

2011 43.7 77.9

2012 60.6 71.4

2013 50.9 107.3


11/30

Total Income Glaxo Sanofi Industry

Dec 09(12) 2057.93 1,165.22 10,001.69

Dec 10(12) 2279.56 1,364.40 14,180.58

Dec 11(12) 2591.92 1,467.07 12,349.97

Dec 12(12) 2771.2 1,623.14 11,449.32

Dec 13(12) 2826.21 1,901.57 18,852.62

Total

Expenditure Glaxo Sanofi Industry

Dec 09(12) 1267.93 906.34 8148.72

Dec 10(12) 1,420.54 1,032.03 14,217.93

Dec 11(12) 1,972.12 1,151.52 9,850.70

Dec 12(12) 1,906.79 1,270.16 8,905.19

Dec 13(12) 2,077.00 1,420.43 18,321.27

PBIDT Glaxo Sanofi Industry

Dec 09(12) 790 258.88 1852.97

Dec 10(12) 859.02 332.37 -37.34

Dec 11(12) 619.80 315.55 2,499.25

Dec 12(12) 864.40 352.98 2,544.13

Dec 13(12) 749.20 481.14 531.34

PBDT Glaxo Sanofi Industry PBT Glaxo Sanofi Industry

Dec 09(12) 789.63 258.81 1829.3 Dec 09(12) 773.26 241.47 284.24

Dec 10(12) 858.40 329.48 -60.33 Dec 10(12) 840.77 309.74 2,368.76

Dec 11(12) 619.47 315.13 2,476.55 Dec 11(12) 599.06 283.98 2,289.11Dec 12(12) 864.40 351.58 2,543.31 Dec 12(12) 846.56 261.71 -181.81

Dec 13(12) 749.20 480.72 506.62 Dec 13(12) 729.32 388.46 1,748.98


12/30

PAT Glaxo Sanofi Industry

Dec 09(12) 502.51 157.58 1111.04

Dec 10(12) 580.73 155.22 -594.97

Dec 11(12) 591.27 191.19 1,616.98Dec 12(12) 673.82 176.71 1,269.61

Dec 13(12) 482.90 239.96 196.12


13/30


Industry :Pharmaceuticals - Multinational

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Appropriation to Capital Redemption Reserve 0 0 0 0 0

Appropriation to Debenture Redemption Reserve 0 0 0 0 0

Appropriation to General Reserve 50.19 57.73 43.06 56.37 51.23

Appropriation to Investment Allowance Reserve 0 0 0 0 0

Appropriation to Other Reserves 0 0 0 0 0

Prior Year Dividend Paid 0 0 0 0 0

Provision for Equity Dividend 423.5 423.5 381.2 338.8 254.1

Provision for Preference Dividend 0 0 0 0 0

Dividend Tax 71.19 63.66 60.32 53.21 40.13

INTERIM DIVIDEND PAID 0 0 0 0 0

Company >> Finance >> Profit & Loss

Break up of Appropriations

(Rs in Crs)


14/30

Sanofi

India Ltd

Industry

:Pharmac

euticals -Multinati

onal

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Appropriati 0 0 0 0 0


Appropriati 26.52 17.67 19.11 23.08 15.74



Prior Year 0 0 0 0 0

Provision f 103.64 76 76 126.67 46.06

Provision f 0 0 0 0 0

Dividend T 18.12 12.32 11.87 20.89 7.83

INTERIM DI 23.03 9.21 9.21 9.21 8.06

Break up of Appropriations

(Rs in Crs)


15/30


Sanofi

India Ltd

Industry :Pharmaceuticals -

Multinational

Industry

:Pharmac

euticals -Multinati

onal

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12) Year

Tax for the current year 233 294.4 300.65 289.5 274.4 Tax for the

Adjustment for Previous Year 0 0 0 0 0 Adjustmen

Others 0 0 -119.97 -0.74 -0.13 Others


Break up of Tax

(Rs in Crs)

Break up o

(Rs in Crs)


16/30

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

107.87 72.23 74.32 80.85 82.7

0 0 0 -6.58 -1.46

0 0 0 0 0

Tax


17/30



Multinational

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Rent,Rates and Taxes paid 38.04 30.51 20.74 18.82 17.24

Wealth Tax 0 0 0 0 0

Cess 0 0 0 0 0

Others 38.04 30.51 20.74 18.82 17.24

Sales Tax 0 0 0 0 0

Lease Rent / Hire Charges paid 0 0 0 0 0

Insurance 4.43 3.19 3.15 2.93 2.35

Discount paid 0 0 0 0 0

Advertisement 0 0 106.2 96.25 95.02

Marketing Expenses 120.2 99.66 0 0 0

Commssion expenses on sales 0 0 0 0.05 0.03

Distribution Expenses 54.42 48.76 39.96 34.28 26.79

Other Selling Expenses 0 0 0 0 0

Legal Expenses 0 0 0 0 0

Communication Expenses 12.96 15.36 0 0 0Travel Expenses 58.05 56.82 48.87 40.13 34.91

Audit Expenses 1.26 0.95 0.93 0.94 0.94

Printing and Stationery 0 0 13.55 12.58 10.71

Royalty and technical fees 0 0 0 0 0

Other Fee Expenses 0 0 0 0 0

Director's Remuneration 0.61 0.61 0.56 6.85 5.83

Other Commission paid 11.67 12.09 11.27 10.25 9.27

R & D Expenses 0 0 3.83 4.43 4.67

Other Administrative Expenses 19.44 18.11 19.97 19.24 11.93


Break up of Selling and Administration Expenses

(Rs in Crs)


18/30

Sanofi

India Ltd

Industry

:Pharmac

euticals -Multinati

onal

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Rent,Rates 24.74 23.06 15.51 12.11 12.91

Wealth Tax 0 0 0 0 0

Cess 0 0 0 0 0

Others 24.74 23.06 15.51 12.11 12.91

Sales Tax 0 0 0 0 0

Lease Rent 0 0 0 0 0

Insurance 5.75 5.85 5.22 4.72 5.27

Discount p 0 0 0 0 0

Advertisem 94.57 92.93 80.02 72.31 57.82

Marketing 0 0 0 0 0

Commssio 0 0 0 0 0

Distributio 86.67 68.99 61.73 52.5 38.37

Other Selli 0 0 0 0 0

Legal Expe 9.74 9.97 10.96 14.38 8.73

Communic 0 0 0 0 0Travel Exp 60.33 58.42 49.54 44.94 39.92

Audit Expe 0.66 0.62 0.54 0.47 0.45

Printing an 0 0 0 0 0

Royalty an 0 0 0 0 0

Other Fee 0 0 0 0 0

Director's 0 0 0 2 2.92

Other Com 0 0 0 0 0

R & D Expe 0 0 0 0 5.14

Other Adm 24.3 21.05 11.68 10.73 9.08

Break up of Selling and Administration Expenses

(Rs in Crs)


19/30



Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Freight Inwards & Transport charges 0 0 0 0 0

Packing Materials 0 0 0 0 0

Job Work / Contract / Processing Charges 0 0 0 0 0

Drilling Operation Charges 0 0 0 0 0

Stores Consumed 4.16 3.56 3.15 3.46 4.02

Repairs 13.03 12.03 13.45 16.46 14.71

Repairs - Plant & machinery 9.61 9.68 10.58 12.11 11.08

Repairs - Building 3.3 2.21 2.74 4.13 3.33

Repairs - Others 0.12 0.13 0.13 0.22 0.3

Technical fees paid 0 0 0 0 0

Wheeling charges payable 0 0 0 0 0

Project / Production Charges 0 0 0 0 0

Own Film Production Expense 0 0 0 0 0

Handling, Clearing Charges 0 0 0 0 0

Coupon Sales, Food, Beverages 0 0 0 0 0

License Fee / Operation Charges 0 0 0 0 0Other Operating Expenses 73.73 48.99 57.9 44.77 40.94


Break up of Other Manufacturing Expenses

(Rs in Crs)


20/30

Industry

:Pharmac

euticals -

Multinational

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Freight Inw 0 0 0 0 0

Packing M 0 0 0 0 0

Job Work / 0 0 0 28.32 22.97

Drilling Op 0 0 0 0 0

Stores Con 2.78 2.7 2.33 3.21 2.52

Repairs 17.82 14.39 12.84 10.15 9.19

Repairs - Pl 6.69 5.06 4.58 2.9 2.33

Repairs - B 0.73 0.92 1.1 1.35 1.39

Repairs - O 10.4 8.41 7.16 5.9 5.47

Technical f 0 0 0 0 0

Wheeling c 0 0 0 0 0

Project / P 0 0 0 0 0

Own Film P 0 0 0 0 0

Handling, 0 0 0 0 0

Coupon Sal 0 0 2.55 0 0

License Fe 0 0 0 0 0Other Ope 30.66 32.34 28.09 5.22 5.03

Break up of Other Manufacturing Expenses

(Rs in Crs)


21/30

Glaxosmithkline Pharma

Ltd


Multinational

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Salaries,Wages & Bonus 326.1 262.9 250.2 211.4 183.4

Contribution to funds 16.35 14.18 17.8 12.41 11.68

Staff Welfare Expenses 14.57 14.09 10.36 10.69 8.94

VRS compensation 0.05 98.06 9.13 0 0

Gratuity Paid 5.02 4.35 0 0 0

Other Employee Cost 0 0 0 0 0


Break up of Employee Cost

(Rs in Crs)


22/30

Sanofi

India Ltd

Industry

:Pharmac

euticals -Multinati

onal

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Salaries,W 214.71 191.85 155.34 140.58 122.5

Contributio 12.92 9.83 11.54 11.77 10.57

Staff Welfa 14.5 12.1 9.54 8.9 7.96

VRS compe 0 0 0 0 0

Gratuity Pa 0 0 0 0 0

Other Empl 0 0 0 0 0

Break up of Employee Cost

(Rs in Crs)


23/30



Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Opening Stock of Raw Materials 0 0 62.31 54.92 62.35

Purchases of Raw Material 538.57 437.81 425.96 427.21 389.23

Purchase of Trading Goods 670 607.45 533.37 377.37 327.97

Direct Expense on Purchase/Adjustment 0 0 0 0 0

Closing Stock of Raw Materials 0 0 57.04 62.31 54.92

Adjustment on amalgamation / trial runs 0 0 0 0 0


Break up of Raw Materials

(Rs in Crs)


24/30

Sanofi

India Ltd

Industry

:Pharmac

euticals -Multinati

onal

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Opening St 109.78 100.53 94.86 101.42 64.86

Purchases 696.21 568.36 497.22 439.88 420.08

Purchase o 190.77 185.31 135.38 104.58 120.89

Direct Exp 0 0 0 0 0

Closing Sto 167.86 109.78 100.53 94.86 101.42

Adjustmen 0 0 0 0 1.01

Break up of Raw Materials

(Rs in Crs)


25/30

Sales turno 2,593.39 2,669.97 2,391.73 2,155.08 1,912.77

Other Ope 25.98 26.5 37.85 0 0


26/30

Sanofi

India Ltd

Industry:Pharmac

euticals -

Multinati

onal

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Sales turno 1,752.45 1,533.63 1,258.61 1,107.26 995.79

Job Work 90.71 69.96 59.62 0 0

Pool Accou 0 0 0 0 0

Other Ope 11.69 9.23 11.97 0 0

Discount R 0 0 0 0 0


Break up of Sales Turnover

(Rs in Crs)


27/30

Interest Income 173.15 171.48 141.95 97.33 82.27

Profit on sale of Fixed Assets 22.83 0.18 0 0.49 9.3

Profit on sale of investments 0.09 0 0 0.02 0

Rent received 0.65 0.66 0 0.64 0.57

Gain on Cancell. of Forward Contr/forex trans 0 0 0 1.43 0

Compensation / Reimbursement Income 0 0 0 0 1.25

Other commission Income 0 0 0 2.29 2.76

Provision Written Back 6.06 3.03 0 7.93 2.72

Miscellaneous Income 1.53 0 0 18.78 34.78


28/30

Sanofi

India Ltd

Industry

:Pharmaceuticals -

Multinati

onal

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Export Ince 0 0 0 7.52 7.97

Import Enti 0 0 0 0 0

Dividend In 0.02 0.04 0.01 4.92 1.97

Interest In 32.89 28.45 53.87 34.08 31.08

Interest on 0 0 0 0 0

Profit on s 0 0 0 0 0

Profit on s 0 0 0 75.74 0

Profit on b 0 0 0 0 0

Profit on b 0 0 0 0 0

Profit on p 0 0 0 0 0

Rent receiv 10.92 10.26 10.33 10.88 12.25

Lease Rent 0 0 0 0 0

Gain on Ca 6.81 1.03 0 0 1

Sale of Scr 0 0 0 0 0Compensat 0 0 87.72 78.2 56.22

Refunds / 0 0 0 2.3 3.53

Income fro 0 0 0 0 0

Fee Incom 0 0 0 51.31 44.47



Other com 0 0 0 0 0







Profit on in 0 0 0 0 0

Sale of Po 0 0 0 0 0

Wheeling 0 0 0 0 0

Provision 6.27 0.03 0.03 0 6.91

Miscellane 26.33 1.36 3.65 2.47 1.95


Break up of Other Income

(Rs in Crs)


29/30

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Closing Stock Of WIP 32.34 33.33 54.6 51.76 41.86

Closing Stock of Finished Goods 236.61 184.87 216.18 162.93 152.64

Closing Stock of Other Materials 0 0 0 0 0

Opening Stock of WIP 33.33 54.6 51.76 41.86 36.9

Opening Stock of Finished Goods 184.87 216.18 162.93 152.64 125.19

Opening Stock of Other Materials 0 0 0 0 0

Adjustment on amalgamation / trial runs 0 0 0 0 0


30/30

Sanofi

India Ltd

Industry

:Pharmaceuticals -

Multinati

onal

Year

Dec

13(12)

Dec

12(12)

Dec

11(12)

Dec

10(12)

Dec

09(12)

Closing Sto 32.68 29.08 27.92 23.65 21.34

Closing Sto 139.46 133.59 125.82 119.96 108.38

Closing Sto 0 0 0 0 0

Opening St 29.08 27.92 23.65 21.34 28.21

Opening St 133.59 125.82 119.96 108.38 79.48

Opening St 0 0 0 0 0

Adjustmen 0 0 -0.01 -1.86 1.43


Break up of Stock Adjustments

(Rs in Crs)

fra project

Documents